Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.
You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!
If you have any problems with the registration process or your account login, please contact contact us.
Press Release: New Research May Help Pave the Way for Shorter Hospital Stays for Patients With Diabetes
Quote:
March 14, 2007 -- Protocol-driven insulin therapy on the medical-surgical wards resulted in better glucose control, as compared to individualized management in patients with diabetic foot ulcers. As a result, shorter hospital stays may be possible. These new findings will be presented at the American Association of Clinical Endocrinologists (AACE) Sixteenth Annual Meeting and Clinical Congress, which will be held April 11 - 15 at the Washington State Convention & Trade Center in Seattle.
"This is the first randomized pilot trial to showcase how intensive subcutaneous insulin protocol on medical-surgical wards can help to improve diabetes control," Alicia Leung, MD, at Stroger Hospital of Cook County in Chicago said. "Diabetes clinical pathway applied to routine management of surgical patients on the wards of public hospitals resulted in superior glucose control."
A group of 23 patients with type 2 Diabetes Mellitus were admitted for surgical management of diabetic foot ulcers. Once routine medical consultation for preoperative evaluation of high glucose was requested, patients were randomly assigned to a medical consult physician providing individualized glycemic management or medical consult physician trained in protocol-driven subcutaneous insulin therapy twice a day.
"Those patients who received the protocol-driven insulin therapy were in the hospital roughly 2.5 days less than those who received the individualized glycemic management, discharge decisions being made by a surgical team based on wound healing and regardless of glucose control," Dr. Leung said. "This clinically significant difference eventually supported implementation of hospital-wide subcutaneous insulin protocol at Stroger Hospital, limiting the size of our study -- thus we were able to show only a marginal statistical significance. Optimal glucose control is known to improve wound healing and also make diabetic patients less susceptible to bacterial infections."
"Our study shows that protocol-driven insulin therapy results in a better glycemic outcome, improving the quality of care and achieving standard of care goals," Dr. Leung said.
"Endocrinology expertise is important in implementing and trouble-shooting insulin protocol, identifying patients that do not fit standard care," Dr. Jurado, currently a hospitalist at Saint Luke's Hospital in Jacksonville, FL, said. "However, hyperglycemia being the fourth most common co-morbid condition in the hospital, clinical pathways for glucose management can be successfully delivered by hospitalists and house staff physicians."
This original research is being presented by Alicia Leung, MD, and Gustavo A. Jurado, MD, in collaboration with Ikna Espinosa, DO, Sylvia Velinova, MD, and Rasa Kazlauskaite, MD, FACE. The study took place at the Stroger Hospital of Cook County in Chicago
Glucose control in hospitalized diabetic foot ulcers
Linear Mode
